NASDAQ: ACLXArcellx Inc Stock Ownership - Who owns Arcellx?
Insider buying vs selling
Have Arcellx Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kavita Patel | Director | 2025-03-18 | 1,500 | $71.64 | $107.46kSell |
| Kavita Patel | Director | 2025-03-18 | 1,500 | $6.66 | $9.99kBuy |
| Rami Elghandour | President CEO and Chairman of the Board | 2025-02-26 | 6,334 | $61.14 | $387.25kSell |
| Rami Elghandour | President CEO and Chairman of the Board | 2025-02-26 | 10,889 | $62.69 | $682.62kSell |
| Rami Elghandour | President CEO and Chairman of the Board | 2025-02-26 | 21,077 | $61.95 | $1.31MSell |
| Kavita Patel | Director | 2025-02-25 | 1,500 | $6.66 | $9.99kBuy |
| Kavita Patel | Director | 2025-02-25 | 1,500 | $63.16 | $94.74kSell |
| Christopher Heery | CHIEF MEDICAL OFFICER | 2025-02-24 | 4,370 | $63.14 | $275.92kSell |
| Christopher Heery | CHIEF MEDICAL OFFICER | 2025-02-24 | 5,577 | $64.26 | $358.36kSell |
| Christopher Heery | CHIEF MEDICAL OFFICER | 2025-02-24 | 208 | $64.88 | $13.49kSell |
ACLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ACLX insiders and whales buy or sell their stock.
ACLX Shareholders
What type of owners hold Arcellx Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 14.48% | 7,956,633 | $567.71M | Institution |
| Gilead Sciences Inc | 12.23% | 6,720,803 | $479.53M | Insider |
| Gilead Sciences Inc | 12.23% | 6,720,803 | $479.53M | Institution |
| Sr One Capital Management LLC | 11.87% | 6,520,370 | $465.23M | Insider |
| Jill Carroll | 11.54% | 6,340,738 | $452.41M | Insider |
| Scott D. Sandell | 8.64% | 4,748,116 | $338.78M | Insider |
| Peter W. Sonsini | 8.64% | 4,746,083 | $338.63M | Insider |
| Mohamad Makhzoumi | 8.64% | 4,745,545 | $338.59M | Insider |
| Forest Baskett | 8.64% | 4,745,262 | $338.57M | Insider |
| New Enterprise Associates 15 LP | 8.64% | 4,745,262 | $338.57M | Insider |
ACLX vs Biotech Stocks
Arcellx Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.